BRAF and cancer: If the miRNA-dependent mechanisms underlying the oncogenesis of BRAF-mutant colorectal cancer are identified, this could lead to discovering novel molecular targets for therapy to improve the outcome of patients with colorectal cancer and even other cancers harboring BRAF mutations.